Researchers found that one in three men had minimal symptomatic benefits from tamsulosin, the most commonly prescribed medication for older men with a form of urinary tract infections, and suggest ...
MIAMI, July 20, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a biopharmaceutical company focused on urology and oncology, today announced that the company has initiated the subject ...
MedPage Today on MSN
Many men with LUTS could be candidates to stop alpha-blocker treatment
Novel N-of-1 study design showed minimal treatment effect for 11 of 30 patients ...
TOKYO, Feb 23 (Reuters) - Japan's Astellas Pharma Inc. <4503.T> said on Friday it had won a suit against Ranbaxy Laboratories Ltd. to prevent the Indian drug maker from releasing an early generic ...
MUMBAI, Dec 10 (Reuters) - Indian drug maker Ranbaxy Laboratories expects to launch a generic version of Astellas Pharma's <4503.T> Flomax urinary drug in March next year, its chief financial officer ...
Incontinent men will do better on both tolterodine (Detrol) and tamsulosin (Flomax) than on either drug alone, urologists report. In the first study of its kind, urologists enrolled 754 men aged 40 ...
Dear Dr. Roach: In a prior column, you discussed an enlarged prostate, or BPH. How does one know if they have BPH or overactive bladder? I wake up three times a night to urinate. I tried Flomax for ...
"If giving someone terazosin or similar medications truly reduces their risk of disease, these results could have significant clinical implications for neurologists," Jacob E. Simmering, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results